Your GP can: Assess your current weight, BMI, and metabolic health to determine clinical need Review existing treatment options that are currently licensed and available in the UK, which may include orlistat, naltrexone/bupropion (Mysimba), semaglutide 2.4 mg (Wegovy approved by the MHRA for weight management and subject to NICE guidance on eligibility, service setting, and treatment duration), and tirzepatide (Mounjaro check current MHRA and NICE status at the time of reading, as licensing and commissioning arrangements may have been updated) Discuss eligibility for NHS Tier 3 or Tier 4 specialist weight management services , in line with NICE guidance on obesity management, where pharmacotherapy is used as an adjunct to structured lifestyle intervention Signpost you to relevant clinical trials via the Be Part of Research portal or ClinicalTrials.gov if you wish to explore participation in retatrutide research It is important to approach information about investigational medicines with appropriate caution

Yet despite these benefits, some patients taking GLP-1 medications report serious gastrointestinal issues (such as gastroparesis and bowel obstruction) and, in other cases, vision injuries claims that now form the backbone of ongoing litigation
How you can use SeekPeptides for pain management SeekPeptides provides personalized pain relief protocols using peptides tailored to your specific pain type and severity
What are the benefits of GHK-Cu peptide for skin and hair
Initial skin irritation Mild irritation affects roughly 5-10% of new copper peptide users